カテゴリー： LP Information, 世界, 医療/バイオ

世界の高性能医薬品有効成分（HPAPI）市場予測 2021年-2026年

【英語タイトル】Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9636）・商品コード：LPI21MY9636
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：160
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「高性能医薬品有効成分（HPAPI）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、合成成分、生物学的成分など、用途別には、腫瘍、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他などにセグメント区分してまとめました。高性能医薬品有効成分（HPAPI）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・高性能医薬品有効成分（HPAPI）の世界市場概要（サマリー）
・高性能医薬品有効成分（HPAPI）の企業別販売量・売上
・高性能医薬品有効成分（HPAPI）の企業別市場シェア
・高性能医薬品有効成分（HPAPI）の世界市場規模 2016年-2021年：種類別（合成成分、生物学的成分）
・高性能医薬品有効成分（HPAPI）の世界市場規模 2016年-2021年：用途別（腫瘍、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他）
・高性能医薬品有効成分（HPAPI）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・高性能医薬品有効成分（HPAPI）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・高性能医薬品有効成分（HPAPI）のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・高性能医薬品有効成分（HPAPI）の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・高性能医薬品有効成分（HPAPI）市場の成長要因・課題・動向
・高性能医薬品有効成分（HPAPI）の世界市場予測 2021年-2026年
・高性能医薬品有効成分（HPAPI）の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・高性能医薬品有効成分（HPAPI）のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・高性能医薬品有効成分（HPAPI）のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・高性能医薬品有効成分（HPAPI）の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・高性能医薬品有効成分（HPAPI）の世界市場予測：種類別（合成成分、生物学的成分）
・高性能医薬品有効成分（HPAPI）の世界市場予測：用途別（腫瘍、緑内障、抗糖尿病、心臓血管、筋骨格、ホルモン、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of High Performance Active Pharmaceutical Ingredients (HPAPI) will have significant change from previous year. By the most conservative estimates of global High Performance Active Pharmaceutical Ingredients (HPAPI) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the High Performance Active Pharmaceutical Ingredients (HPAPI) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of High Performance Active Pharmaceutical Ingredients (HPAPI) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Synthetic Ingredients
Biological Ingredients

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Oncology
Glaucoma
Anti-diabetic
Cardiovascular
Musculoskeletal
Hormonal
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bristol-Myers Squibb
Novartis
Sanofi Aventis
Pfizer
Lonza
Novasep
Hospira
BASF
Merck
Bayer
Teva Pharmaceuticals
Boehringer Ingelheim

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption 2016-2026
2.1.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption CAGR by Region
2.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment by Type
2.2.1 Synthetic Ingredients
2.2.2 Biological Ingredients
2.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type
2.3.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type (2016-2021)
2.3.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Market Share by Type (2016-2021)
2.3.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sale Price by Type (2016-2021)
2.4 High Performance Active Pharmaceutical Ingredients (HPAPI) Segment by Application
2.4.1 Oncology
2.4.2 Glaucoma
2.4.3 Anti-diabetic
2.4.4 Cardiovascular
2.4.5 Musculoskeletal
2.4.6 Hormonal
2.4.7 Others
2.5 High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application
2.5.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sale Market Share by Application (2016-2021)
2.5.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue and Market Share by Application (2016-2021)
2.5.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sale Price by Application (2016-2021)

3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) by Company
3.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Company
3.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Company (2019-2021)
3.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Company (2019-2021)
3.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Company
3.2.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Company (2019-2021)
3.2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Company (2019-2021)
3.3 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sale Price by Company
3.4 Global Manufacturers High Performance Active Pharmaceutical Ingredients (HPAPI) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers High Performance Active Pharmaceutical Ingredients (HPAPI) Product Location Distribution
3.4.2 Players High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 High Performance Active Pharmaceutical Ingredients (HPAPI) by Region
4.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) by Region
4.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Region
4.1.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Region
4.2 Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth
4.3 APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth
4.4 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth
4.5 Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth

5 Americas
5.1 Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country
5.1.1 Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country (2016-2021)
5.1.2 Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Country (2016-2021)
5.2 Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type
5.3 Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Region
6.1.1 APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Region (2016-2021)
6.1.2 APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Region (2016-2021)
6.2 APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type
6.3 APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) by Country
7.1.1 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country (2016-2021)
7.1.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Country (2016-2021)
7.2 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type
7.3 Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) by Country
8.1.1 Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country (2016-2021)
8.1.2 Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Country (2016-2021)
8.2 Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type
8.3 Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 High Performance Active Pharmaceutical Ingredients (HPAPI) Distributors
10.3 High Performance Active Pharmaceutical Ingredients (HPAPI) Customer

11 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Forecast
11.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast by Region
11.1.1 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast by Regions (2021-2026)
11.2.2 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast by Type
11.7 Global High Performance Active Pharmaceutical Ingredients (HPAPI) Forecast by Application

12 Key Players Analysis
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Bristol-Myers Squibb Company Information
12.1.2 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.1.3 Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bristol-Myers Squibb Main Business Overview
12.1.5 Bristol-Myers Squibb Latest Developments
12.2 Novartis
12.2.1 Novartis Company Information
12.2.2 Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.2.3 Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Sanofi Aventis
12.3.1 Sanofi Aventis Company Information
12.3.2 Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.3.3 Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Sanofi Aventis Main Business Overview
12.3.5 Sanofi Aventis Latest Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.4.3 Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Pfizer Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Lonza
12.5.1 Lonza Company Information
12.5.2 Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.5.3 Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Lonza Main Business Overview
12.5.5 Lonza Latest Developments
12.6 Novasep
12.6.1 Novasep Company Information
12.6.2 Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.6.3 Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Novasep Main Business Overview
12.6.5 Novasep Latest Developments
12.7 Hospira
12.7.1 Hospira Company Information
12.7.2 Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.7.3 Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Hospira Main Business Overview
12.7.5 Hospira Latest Developments
12.8 BASF
12.8.1 BASF Company Information
12.8.2 BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.8.3 BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 BASF Main Business Overview
12.8.5 BASF Latest Developments
12.9 Merck
12.9.1 Merck Company Information
12.9.2 Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.9.3 Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Merck Main Business Overview
12.9.5 Merck Latest Developments
12.10 Bayer
12.10.1 Bayer Company Information
12.10.2 Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.10.3 Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Bayer Main Business Overview
12.10.5 Bayer Latest Developments
12.11 Teva Pharmaceuticals
12.11.1 Teva Pharmaceuticals Company Information
12.11.2 Teva Pharmaceuticals High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.11.3 Teva Pharmaceuticals High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Teva Pharmaceuticals Main Business Overview
12.11.5 Teva Pharmaceuticals Latest Developments
12.12 Boehringer Ingelheim
12.12.1 Boehringer Ingelheim Company Information
12.12.2 Boehringer Ingelheim High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
12.12.3 Boehringer Ingelheim High Performance Active Pharmaceutical Ingredients (HPAPI) Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Boehringer Ingelheim Main Business Overview
12.12.5 Boehringer Ingelheim Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. High Performance Active Pharmaceutical Ingredients (HPAPI) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Synthetic Ingredients
Table 3. Major Players of Biological Ingredients
Table 4. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type (2016-2021) & (K MT)
Table 5. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type (2016-2021)
Table 6. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Type (2016-2021) & ($ million)
Table 7. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Type (2016-2021)
Table 8. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sale Price by Type (2016-2021)
Table 9. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application (2016-2021) & (K MT)
Table 10. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2016-2021)
Table 11. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Value by Application (2016-2021)
Table 12. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Application (2016-2021)
Table 13. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sale Price by Application (2016-2021)
Table 14. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Company (2019-2021) & (K MT)
Table 15. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Company (2019-2021)
Table 16. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Company (2019-2021) ($ Millions)
Table 17. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Company (2019-2021)
Table 18. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sale Price by Company (2019-2021)
Table 19. Key Manufacturers High Performance Active Pharmaceutical Ingredients (HPAPI) Producing Area Distribution and Sales Area
Table 20. Players High Performance Active Pharmaceutical Ingredients (HPAPI) Products Offered
Table 21. High Performance Active Pharmaceutical Ingredients (HPAPI) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Region (2016-2021) (K MT)
Table 25. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Region (2016-2021)
Table 26. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Region (2016-2021)
Table 28. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country (2016-2021) & (K MT)
Table 29. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Country (2016-2021)
Table 30. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Country (2016-2021)
Table 32. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type (2016-2021) & (K MT)
Table 33. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type (2016-2021)
Table 34. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application (2016-2021) & (K MT)
Table 35. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2016-2021)
Table 36. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Region (2016-2021) & (K MT)
Table 37. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Region (2016-2021)
Table 38. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Region (2016-2021)
Table 40. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type (2016-2021) & (K MT)
Table 41. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type (2016-2021)
Table 42. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application (2016-2021) & (K MT)
Table 43. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2016-2021)
Table 44. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country (2016-2021) & (K MT)
Table 45. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Country (2016-2021)
Table 46. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Country (2016-2021)
Table 48. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type (2016-2021) & (K MT)
Table 49. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type (2016-2021)
Table 50. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application (2016-2021) & (K MT)
Table 51. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Country (2016-2021) & (K MT)
Table 53. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Type (2016-2021) & (K MT)
Table 57. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Application (2016-2021) & (K MT)
Table 59. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2016-2021)
Table 60. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast by Type (2021-2026) & (K MT)
Table 61. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share Forecast by Type (2021-2026)
Table 62. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Forecast by Application (2021-2026) & (K MT)
Table 65. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share Forecast by Application (2021-2026)
Table 66. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share Forecast by Application (2021-2026)
Table 68. Bristol-Myers Squibb Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 69. Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 70. Bristol-Myers Squibb High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 71. Bristol-Myers Squibb Main Business
Table 72. Bristol-Myers Squibb Latest Developments
Table 73. Novartis Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 74. Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 75. Novartis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 76. Novartis Main Business
Table 77. Novartis Latest Developments
Table 78. Sanofi Aventis Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 80. Sanofi Aventis High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 81. Sanofi Aventis Main Business
Table 82. Sanofi Aventis Latest Developments
Table 83. Pfizer Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 85. Pfizer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Lonza Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 89. Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 90. Lonza High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 91. Lonza Main Business
Table 92. Lonza Latest Developments
Table 93. Novasep Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 94. Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 95. Novasep High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 96. Novasep Main Business
Table 97. Novasep Latest Developments
Table 98. Hospira Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 99. Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 100. Hospira High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 101. Hospira Main Business
Table 102. Hospira Latest Developments
Table 103. BASF Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 104. BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 105. BASF High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 106. BASF Main Business
Table 107. BASF Latest Developments
Table 108. Merck Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 109. Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 110. Merck High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 111. Merck Main Business
Table 112. Merck Latest Developments
Table 113. Bayer Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 114. Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 115. Bayer High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 116. Bayer Main Business
Table 117. Bayer Latest Developments
Table 118. Teva Pharmaceuticals Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 119. Teva Pharmaceuticals High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 120. Teva Pharmaceuticals High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 121. Teva Pharmaceuticals Main Business
Table 122. Teva Pharmaceuticals Latest Developments
Table 123. Boehringer Ingelheim Basic Information, High Performance Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base, Sales Area and Its Competitors
Table 124. Boehringer Ingelheim High Performance Active Pharmaceutical Ingredients (HPAPI) Product Offered
Table 125. Boehringer Ingelheim High Performance Active Pharmaceutical Ingredients (HPAPI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 126. Boehringer Ingelheim Main Business
Table 127. Boehringer Ingelheim Latest Developments
List of Figures
Figure 1. Picture of High Performance Active Pharmaceutical Ingredients (HPAPI)
Figure 2. High Performance Active Pharmaceutical Ingredients (HPAPI) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. High Performance Active Pharmaceutical Ingredients (HPAPI) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Synthetic Ingredients
Figure 10. Product Picture of Biological Ingredients
Figure 11. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type in 2020
Figure 12. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Type (2016-2021)
Figure 13. High Performance Active Pharmaceutical Ingredients (HPAPI) Consumed in Oncology
Figure 14. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market: Oncology (2016-2021) & (K MT)
Figure 15. High Performance Active Pharmaceutical Ingredients (HPAPI) Consumed in Glaucoma
Figure 16. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market: Glaucoma (2016-2021) & (K MT)
Figure 17. High Performance Active Pharmaceutical Ingredients (HPAPI) Consumed in Anti-diabetic
Figure 18. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market: Anti-diabetic (2016-2021) & (K MT)
Figure 19. High Performance Active Pharmaceutical Ingredients (HPAPI) Consumed in Cardiovascular
Figure 20. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market: Cardiovascular (2016-2021) & (K MT)
Figure 21. High Performance Active Pharmaceutical Ingredients (HPAPI) Consumed in Musculoskeletal
Figure 22. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market: Musculoskeletal (2016-2021) & (K MT)
Figure 23. High Performance Active Pharmaceutical Ingredients (HPAPI) Consumed in Hormonal
Figure 24. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market: Hormonal (2016-2021) & (K MT)
Figure 25. High Performance Active Pharmaceutical Ingredients (HPAPI) Consumed in Others
Figure 26. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market: Others (2016-2021) & (K MT)
Figure 27. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application (2016-2021)
Figure 28. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Application in 2020
Figure 29. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market by Company in 2020 ($ Million)
Figure 30. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Company in 2020
Figure 31. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Regions (2016-2021)
Figure 32. Global High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Region in 2020
Figure 33. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales 2016-2021 (K MT)
Figure 34. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue 2016-2021 ($ Millions)
Figure 35. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales 2016-2021 (K MT)
Figure 36. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue 2016-2021 ($ Millions)
Figure 37. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales 2016-2021 (K MT)
Figure 38. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue 2016-2021 ($ Millions)
Figure 39. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales 2016-2021 (K MT)
Figure 40. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue 2016-2021 ($ Millions)
Figure 41. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Country in 2020
Figure 42. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Country in 2020
Figure 43. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type in 2020
Figure 44. Americas High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application in 2020
Figure 45. United States High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 46. Canada High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 47. Mexico High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 48. Brazil High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 49. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Region in 2020
Figure 50. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Regions in 2020
Figure 51. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type in 2020
Figure 52. APAC High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application in 2020
Figure 53. China High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 54. Japan High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 55. Korea High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 56. Southeast Asia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 57. India High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 58. Australia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 59. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Country in 2020
Figure 60. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Country in 2020
Figure 61. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type in 2020
Figure 62. Europe High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application in 2020
Figure 63. Germany High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 64. France High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 65. UK High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 66. Italy High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 67. Russia High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 68. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Country in 2020
Figure 69. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Country in 2020
Figure 70. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Type in 2020
Figure 71. Middle East & Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Sales Market Share by Application in 2020
Figure 72. Egypt High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 73. South Africa High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 74. Israel High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 75. Turkey High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 76. GCC Country High Performance Active Pharmaceutical Ingredients (HPAPI) Revenue Growth 2016-2021 ($ Millions)
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles


★調査レポート[世界の高性能医薬品有効成分（HPAPI）市場予測 2021年-2026年] (コード：LPI21MY9636)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の高性能医薬品有効成分（HPAPI）市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の高性能医薬品有効成分(HPAPI)市場 2019年
    DATA909X09035 / QYResearch / 2019年11月20日 / ※本調査レポートは、高性能医薬品有効成分(HPAPI)の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、合成成分、生物学的成分、その他に、用途別には、腫瘍学、緑内障、抗糖尿病、心血管、筋骨格、ホルモン、その他にセグメント区分し、高性能医薬品有効成分(HPAPI)の世界市場を分析しました。 ・エグゼクティブ・サマリー ・高性能医薬品有効成分(HPAPI)の世界市場概要 ・高性能医薬品有効成分(HPAPI)の製造コスト構成分析 ・高性能医薬品有効成分(HPAPI)の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・高性能医薬品有効成分(HPAPI)の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・高性能医薬品有効成分(HPAPI)のセグメント分析（種類別） （合成成分、生物学的成分、その他）...The global High Performance Active Pharmaceutical Ingredients (HPAPI) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on High Performance Active Pharmaceutical Ingredients (HPAPI) volume and value at global level, regional level and company level. From a global perspective, this report represents overall High Performance Active Pharmaceutical Ingredients (HPAPI) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of High Performance Active Pharmaceutical Ingredients (HPAPI) in North America, Europe, China,...
  • 世界のアスピリン医薬品有効成分（API）市場予測 2021年-2026年
    LPI21MY0738 / LP Information / 2021年5月 / LPインフォメーション社の「アスピリン医薬品有効成分（API）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度（99％～99.5％）、純度（99.5％以上）、純度（99％以下）など、用途別には、安静時疼痛、発熱、炎症、その他などにセグメント区分してまとめました。アスピリン医薬品有効成分（API）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・アスピリン医薬品有効成分（API）の世界市場概要（サマリー） ・アスピリン医薬品有効成分（API）の企業別販売量・売上 ・アスピリン医薬品有効成分（API）の企業別市場シェア ・アスピリン医薬品有効成分（API）の世界市場規模 2016年-2021年：種類別（純度（99％～99.5％）、純度（99.5％以上）、純度（99％以下）） ・アスピリン医薬品有効成分（API）の世界市場規模 2016年-2021年：用途別（安静時疼痛、発熱、炎症、その他） ・アスピリン医薬品有効成分（API）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・アスピリン医薬品有効成分（API）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Aspirin Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Aspirin Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Aspirin Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Aspirin Active Pharmaceutical Ingredients...
  • 世界のパラセタモール有効成分市場予測 2021年-2026年
    LPI21MY2144 / LP Information / 2021年5月 / LPインフォメーション社の「パラセタモール有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度（99％-99.5％）、純度（99.5％以上）、純度（99％以下）など、用途別には、頭痛＆発熱、風邪＆咳、筋肉けいれん、その他などにセグメント区分してまとめました。パラセタモール有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・パラセタモール有効成分の世界市場概要（サマリー） ・パラセタモール有効成分の企業別販売量・売上 ・パラセタモール有効成分の企業別市場シェア ・パラセタモール有効成分の世界市場規模 2016年-2021年：種類別（純度（99％-99.5％）、純度（99.5％以上）、純度（99％以下）） ・パラセタモール有効成分の世界市場規模 2016年-2021年：用途別（頭痛＆発熱、風邪＆咳、筋肉けいれん、その他） ・パラセタモール有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・パラセタモール有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Paracetamol Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Paracetamol Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Paracetamol Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Paracetamol Active Pharmaceutical Ingredients...
  • 世界の解熱鎮痛薬用有効成分市場予測 2021年-2026年
    LPI21MY0712 / LP Information / 2021年5月 / LPインフォメーション社の「解熱鎮痛薬用有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他など、用途別には、頭痛・発熱、風邪・咳、筋肉痙攣、その他などにセグメント区分してまとめました。解熱鎮痛薬用有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・解熱鎮痛薬用有効成分の世界市場概要（サマリー） ・解熱鎮痛薬用有効成分の企業別販売量・売上 ・解熱鎮痛薬用有効成分の企業別市場シェア ・解熱鎮痛薬用有効成分の世界市場規模 2016年-2021年：種類別（パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他） ・解熱鎮痛薬用有効成分の世界市場規模 2016年-2021年：用途別（頭痛・発熱、風邪・咳、筋肉痙攣、その他） ・解熱鎮痛薬用有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・解熱鎮痛薬用有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Antipyretic Analgesic Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Antipyretic Analgesic Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Antipyretic Analgesic Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic...
  • 世界のアクティブ力率補償器（APFC）市場予測 2021年-2026年
    LPI21MY5652 / LP Information / 2021年5月 / LPインフォメーション社の「アクティブ力率補償器（APFC）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、低電圧APFC、高電圧APFCなど、用途別には、再生可能エネルギー、電気事業、工業・製造、その他などにセグメント区分してまとめました。アクティブ力率補償器（APFC）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・アクティブ力率補償器（APFC）の世界市場概要（サマリー） ・アクティブ力率補償器（APFC）の企業別販売量・売上 ・アクティブ力率補償器（APFC）の企業別市場シェア ・アクティブ力率補償器（APFC）の世界市場規模 2016年-2021年：種類別（低電圧APFC、高電圧APFC） ・アクティブ力率補償器（APFC）の世界市場規模 2016年-2021年：用途別（再生可能エネルギー、電気事業、工業・製造、その他） ・アクティブ力率補償器（APFC）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・アクティブ力率補償器（APFC）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Active Power Factor Compensators (APFC) will have significant change from previous year. By the most conservative estimates of global Active Power Factor Compensators (APFC) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Active Power Factor Compensators (APFC) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Active...
  • 世界の農薬用有効成分市場予測 2021年-2026年
    LPI21MY0008 / LP Information / 2021年5月 / LPインフォメーション社の「農薬用有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、アセフェート、バチルスチューリンゲンシス（Bt）、ベンディオカルブ、ビフェントリン、アゾキシストロビン、ボスカリド、フルジオキソニル、1-メチルシクロプロペン、ベンジルアデニンなど、用途別には、殺虫剤、殺菌剤、除草剤、植物成長調節剤、殺鼠剤、その他などにセグメント区分してまとめました。農薬用有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・農薬用有効成分の世界市場概要（サマリー） ・農薬用有効成分の企業別販売量・売上 ・農薬用有効成分の企業別市場シェア ・農薬用有効成分の世界市場規模 2016年-2021年：種類別（アセフェート、バチルスチューリンゲンシス（Bt）、ベンディオカルブ、ビフェントリン、アゾキシストロビン、ボスカリド、フルジオキソニル、1-メチルシクロプロペン、ベンジルアデニン） ・農薬用有効成分の世界市場規模 2016年-2021年：用途別（殺虫剤、殺菌剤、除草剤、植物成長調節剤、殺鼠剤、その他） ・農薬用有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・農薬用有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Agrochemical Active Ingredients will have significant change from previous year. By the most conservative estimates of global Agrochemical Active Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Agrochemical Active Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Agrochemical Active Ingredients market by product type,...
  • 世界の酸性ピロリン酸ナトリウム（SAPP）市場予測 2021年-2026年
    LPI21MY2664 / LP Information / 2021年5月 / LPインフォメーション社の「酸性ピロリン酸ナトリウム（SAPP）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、食品用、工業用など、用途別には、食品、接着剤、分散剤、金属イオン錯体剤、その他などにセグメント区分してまとめました。酸性ピロリン酸ナトリウム（SAPP）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・酸性ピロリン酸ナトリウム（SAPP）の世界市場概要（サマリー） ・酸性ピロリン酸ナトリウム（SAPP）の企業別販売量・売上 ・酸性ピロリン酸ナトリウム（SAPP）の企業別市場シェア ・酸性ピロリン酸ナトリウム（SAPP）の世界市場規模 2016年-2021年：種類別（食品用、工業用） ・酸性ピロリン酸ナトリウム（SAPP）の世界市場規模 2016年-2021年：用途別（食品、接着剤、分散剤、金属イオン錯体剤、その他） ・酸性ピロリン酸ナトリウム（SAPP）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・酸性ピロリン酸ナトリウム（SAPP）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Sodium Acid Pyrophosphate (SAPP) will have significant change from previous year. By the most conservative estimates of global Sodium Acid Pyrophosphate (SAPP) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Sodium Acid Pyrophosphate (SAPP) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Acid Pyrophosphate (SAPP)...
  • 世界の超音波プローブ高レベル消毒器（HLD）市場予測 2021年-2026年
    LPI21MY9314 / LP Information / 2021年5月 / LPインフォメーション社の「超音波プローブ高レベル消毒器（HLD）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、自動消毒器、手動消毒器など、用途別には、病院、クリニック、画像センター、研究所などにセグメント区分してまとめました。超音波プローブ高レベル消毒器（HLD）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・超音波プローブ高レベル消毒器（HLD）の世界市場概要（サマリー） ・超音波プローブ高レベル消毒器（HLD）の企業別販売量・売上 ・超音波プローブ高レベル消毒器（HLD）の企業別市場シェア ・超音波プローブ高レベル消毒器（HLD）の世界市場規模 2016年-2021年：種類別（自動消毒器、手動消毒器） ・超音波プローブ高レベル消毒器（HLD）の世界市場規模 2016年-2021年：用途別（病院、クリニック、画像センター、研究所） ・超音波プローブ高レベル消毒器（HLD）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・超音波プローブ高レベル消毒器（HLD）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Ultrasound Probes High-Level Disinfector(HLD) will have significant change from previous year. By the most conservative estimates of global Ultrasound Probes High-Level Disinfector(HLD) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Ultrasound Probes High-Level Disinfector(HLD) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Ultrasound Probes High-Level Disinfector(HLD)...
  • 世界の高温ヒートポンプ（≥100℃）市場予測 2021年-2026年
    LPI21MY7847 / LP Information / 2021年5月 / LPインフォメーション社の「高温ヒートポンプ（≥100℃）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、出力温度100°C-109°C、出力温度110°C-119°C、出力温度120°C-139°C、出力温度140°C-159°C、出力温度≥160°Cなど、用途別には、化学、紙・パルプ、食品産業、地域暖房、機械製造、石油精製産業、金属産業、その他などにセグメント区分してまとめました。高温ヒートポンプ（≥100℃）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・高温ヒートポンプ（≥100℃）の世界市場概要（サマリー） ・高温ヒートポンプ（≥100℃）の企業別販売量・売上 ・高温ヒートポンプ（≥100℃）の企業別市場シェア ・高温ヒートポンプ（≥100℃）の世界市場規模 2016年-2021年：種類別（出力温度100°C-109°C、出力温度110°C-119°C、出力温度120°C-139°C、出力温度140°C-159°C、出力温度≥160°C） ・高温ヒートポンプ（≥100℃）の世界市場規模 2016年-2021年：用途別（化学、紙・パルプ、食品産業、地域暖房、機械製造、石油精製産業、金属産業、その他） ・高温ヒートポンプ（≥100℃）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・高温ヒートポンプ（≥100℃）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of High Temperature Heat Pumps (≥100℃) will have significant change from previous year. By the most conservative estimates of global High Temperature Heat Pumps (≥100℃) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the High Temperature Heat Pumps (≥100℃) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of High...
  • 世界のハイスピードカメラ（5MP以上）市場予測 2021年-2026年
    LPI21MY7421 / LP Information / 2021年5月 / LPインフォメーション社の「ハイスピードカメラ（5MP以上）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、可視RGB、赤外線、X線など、用途別には、自動車・運輸業、工業製造工場、食品・飲料業、家電産業、エンターテインメント・メディア産業、スポーツ産業、製紙・印刷業、航空宇宙・防衛、研究所、設計・試験所、その他などにセグメント区分してまとめました。ハイスピードカメラ（5MP以上）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ハイスピードカメラ（5MP以上）の世界市場概要（サマリー） ・ハイスピードカメラ（5MP以上）の企業別販売量・売上 ・ハイスピードカメラ（5MP以上）の企業別市場シェア ・ハイスピードカメラ（5MP以上）の世界市場規模 2016年-2021年：種類別（可視RGB、赤外線、X線） ・ハイスピードカメラ（5MP以上）の世界市場規模 2016年-2021年：用途別（自動車・運輸業、工業製造工場、食品・飲料業、家電産業、エンターテインメント・メディア産業、スポーツ産業、製紙・印刷業、航空宇宙・防衛、研究所、設計・試験所、その他） ・ハイスピードカメラ（5MP以上）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ハイスピードカメラ（5MP以上）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of More Than 5 MP High-speed Camera will have significant change from previous year. By the most conservative estimates of global More Than 5 MP High-speed Camera market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the More Than 5 MP High-speed Camera market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth...

    • ◆H&Iグローバルリサーチのお客様（例）◆